Fusion Pharmaceuticals Inc
(FUSN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 44,315 | 106,481 | 61,953 | 59,640 | 53,567 |
| Marketable Securities | 127,013 | 99,429 | 136,899 | 137,601 | 147,897 |
| Receivables | 61 | 215 | 177 | 325 | 357 |
| TOTAL | $178,998 | $215,846 | $207,075 | $204,777 | $211,762 |
| Non-Current Assets | |||||
| PPE Net | 4,631 | 3,851 | 3,506 | 3,398 | 2,967 |
| Investments And Advances | 15,761 | 0 | 0 | 9,901 | 19,987 |
| Other Non-Current Assets | 19,674 | 18,796 | 17,554 | 17,884 | 17,555 |
| TOTAL | $40,066 | $22,647 | $21,060 | $31,183 | $40,509 |
| Total Assets | $219,064 | $238,493 | $228,135 | $235,960 | $252,271 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,686 | 1,311 | 1,551 | 1,774 | 2,195 |
| Accrued Expenses | 10,605 | 10,258 | 7,881 | 7,874 | 7,563 |
| TOTAL | $15,067 | $13,412 | $11,576 | $12,182 | $12,511 |
| Non-Current Liabilities | |||||
| Long Term Debt | 34,233 | 34,106 | 9,629 | N/A | N/A |
| Deferred Revenues | 333 | 412 | 707 | 1,100 | 1,538 |
| Other Non-Current Liabilities | 4,876 | 5,166 | 5,523 | 5,852 | 5,804 |
| TOTAL | $41,776 | $41,939 | $17,652 | $8,352 | $8,304 |
| Total Liabilities | $56,843 | $55,351 | $29,228 | $20,534 | $20,815 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 63,196 | 44,763 | 43,391 | 43,342 | 43,331 |
| Retained earnings | -281,862 | -257,245 | -233,232 | -214,159 | -194,250 |
| Other shareholders' equity | -469 | -1,256 | -1,060 | -578 | -115 |
| TOTAL | $162,221 | $183,142 | $198,907 | $215,426 | $231,456 |
| Total Liabilities And Equity | $219,064 | $238,493 | $228,135 | $235,960 | $252,271 |